Blauvelt, NY (Feb 19, 2013) – RFI is pleased to announce that it has entered into a manufacturing, formulation and sales partnership with Ilhwa NA Inc. (Pearl River, NY), a wholly-owned U.S. subsidiary of Korea’s groundbreaking ginseng company, Ilhwa Co Ltd. Ilhwa manufactures GS15-4™, a high-absorption ginseng extract utilizing a patented high-yield, enzyme-fermented process. Winner of the BEST BOTANICAL 2012 award at Expo West/Engredea, this unique ginseng extract delivers ginseng with higher efficacy, more consistent absorption and an improved taste profile compared to conventional ginseng extracts.
GS15-4™, “the 21st Century Ginseng Extract”, is a breakthrough technology (patents-pending) using enzyme fermentation to produce a completely balanced ginseng extract in its end-stage metabolite form. Human clinical studies have proven that it provides 15 times higher absorption, 4 times faster absorption and 4 times more consistent absorption. GS15-4™ will transform how ginseng can be used in the natural ingredient market.
“Ilhwa is excited to establish this partnership with RFI,” said David C. Konn, president of Ilhwa North America. “RFI is a rare company that has created true vertical integration in the natural ingredient market. As the world leader in ginseng science, Ilhwa wanted to find the right partner to work with on this breakthrough in ginseng technology.”
“GS15-4™ is a great fit with our current product line, especially our energy, stress and fermented product platforms,” said Jeff Wuagneux, president and CEO of RFI. “In addition, Ilhwa’s single passion for ginseng, its strong clinical science and its high quality manufacturing exemplify RFI’s From Field to Formula® motto.”
Established in 1989, RFI is headquartered in Blauvelt, NY. RFI is a formulation-driven company specializing in exceptional products, services and solutions for the dietary supplement, food and beverage industries. Its experienced staff, state-of-the-art facilities and advanced technologies help its customers develop, manufacture and market complete and targeted products. By capitalizing on its natural, organic and science-driven ingredients, existing expertise and global network of manufacturing facilities, RFI does more than just sell ingredients…it offers turnkey products using its Field to Formula® vertically-integrated model. RFI’s extensive network of manufacturing facilities in North America, South America and China provides customers with multiple natural product ingredient solutions worldwide. For more information regarding RFI products, call 800-962-7663 or visit online at www.rfiingredients.com.
Ilhwa Co Ltd, is a high-tech pharmaceutical and nutraceutical company with three divisions: Ginseng, Pharmaceuticals and Beverages. Through continuous scientific research and development for more than four decades, it has become the world leader in ginseng science. Ilhwa is fully KFDA compliant and GMP and ISO certified, holding numerous patents and the publications of 100’s of papers and clinical studies. In 2011, Ilhwa received KFDA approval for a “certified health claim” on it new enzyme fermented ginseng extract to claim “helps to manage blood glucose.” Ilhwa is the first ginseng company to receive this certification.